[
  {
    "ts": null,
    "headline": "Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths",
    "summary": "Moderna shares were down 7.4% Friday—their lowest level since March 2020. The drop brought the drugmaker’s year-to-date slump to more than 44%.",
    "url": "https://finnhub.io/api/news?id=a454bedf0fe9fbfa2676df0e1775039edfbefa9706b3e37fdde80786bebdc3cc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757789782,
      "headline": "Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths",
      "id": 136749651,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Moderna shares were down 7.4% Friday—their lowest level since March 2020. The drop brought the drugmaker’s year-to-date slump to more than 44%.",
      "url": "https://finnhub.io/api/news?id=a454bedf0fe9fbfa2676df0e1775039edfbefa9706b3e37fdde80786bebdc3cc"
    }
  },
  {
    "ts": null,
    "headline": "Legal Uncertainties and Patent Fight Could Be a Game Changer for Pfizer (PFE)",
    "summary": "Earlier this month, Pfizer was named in a proposed US$70.75 million antitrust settlement involving allegations of generic drug price-fixing, and also faced a key patent claim construction ruling in an ongoing lawsuit concerning its COVID-19 vaccine lipid nanoparticle technology. These legal events could affect both Pfizer's financial obligations and the ongoing exclusivity of its vaccine technology, raising uncertainty around future costs and operational outcomes for the company. We’ll look...",
    "url": "https://finnhub.io/api/news?id=0dcedd6894ef1b88174cadc0fdd39fd4b63a5db0154dd7880d6bbd6c69b260aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757771899,
      "headline": "Legal Uncertainties and Patent Fight Could Be a Game Changer for Pfizer (PFE)",
      "id": 136736093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Earlier this month, Pfizer was named in a proposed US$70.75 million antitrust settlement involving allegations of generic drug price-fixing, and also faced a key patent claim construction ruling in an ongoing lawsuit concerning its COVID-19 vaccine lipid nanoparticle technology. These legal events could affect both Pfizer's financial obligations and the ongoing exclusivity of its vaccine technology, raising uncertainty around future costs and operational outcomes for the company. We’ll look...",
      "url": "https://finnhub.io/api/news?id=0dcedd6894ef1b88174cadc0fdd39fd4b63a5db0154dd7880d6bbd6c69b260aa"
    }
  },
  {
    "ts": null,
    "headline": "1 Reason Every Investor Should Know About Pfizer (PFE) Stock",
    "summary": "How does $700 in annual income sound for every $10,000 in shares owned?",
    "url": "https://finnhub.io/api/news?id=34a447925f1cb033eaf304213bda34af37829d9c2184f9c4c3a3629332b1d61b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757754000,
      "headline": "1 Reason Every Investor Should Know About Pfizer (PFE) Stock",
      "id": 136736094,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "How does $700 in annual income sound for every $10,000 in shares owned?",
      "url": "https://finnhub.io/api/news?id=34a447925f1cb033eaf304213bda34af37829d9c2184f9c4c3a3629332b1d61b"
    }
  },
  {
    "ts": null,
    "headline": "Review & Preview: Waiting for the Rate Cut",
    "summary": "The Friday divergence sets up a big week for investors with the Federal Reserve set to meet Tuesday and Wednesday, before announcing its closely watched interest-rate decision Wednesday afternoon.  The tech-heavy Nasdaq stood out today thanks in part to a big gain from Tesla.  “The move comes after Tesla stock added 6% on Thursday, helped in part by in-line inflation data that solidified investors’ belief that rate cuts are coming,” Al wrote today.",
    "url": "https://finnhub.io/api/news?id=14a802790109311b7e36274a149e820b331472ba50a9b27f87fc898742d8a94a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757724900,
      "headline": "Review & Preview: Waiting for the Rate Cut",
      "id": 136735885,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Friday divergence sets up a big week for investors with the Federal Reserve set to meet Tuesday and Wednesday, before announcing its closely watched interest-rate decision Wednesday afternoon.  The tech-heavy Nasdaq stood out today thanks in part to a big gain from Tesla.  “The move comes after Tesla stock added 6% on Thursday, helped in part by in-line inflation data that solidified investors’ belief that rate cuts are coming,” Al wrote today.",
      "url": "https://finnhub.io/api/news?id=14a802790109311b7e36274a149e820b331472ba50a9b27f87fc898742d8a94a"
    }
  }
]